Generation of individualized cancer immuno-therapy independent of HLA-haplotypes
Project/Area Number |
15H04308
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Tumor therapeutics
|
Research Institution | University of Toyama |
Principal Investigator |
Kishi Hiroyuki 富山大学, 大学院医学薬学研究部(医学), 准教授 (60186210)
|
Co-Investigator(Kenkyū-buntansha) |
小澤 龍彦 富山大学, 大学院医学薬学研究部(医学), 助教 (10432105)
村口 篤 富山大学, 大学院医学薬学研究部(医学), 名誉教授 (20174287)
|
Co-Investigator(Renkei-kenkyūsha) |
HAMANA Hiroshi 富山大学, 大学院医学薬学研究部(医学), 客員准教授 (90551549)
NISHIKAWA Hiroyoshi 国立がん研究センター, 先端医療開発センター, 免疫TR分野長 (10444431)
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥16,640,000 (Direct Cost: ¥12,800,000、Indirect Cost: ¥3,840,000)
Fiscal Year 2017: ¥5,590,000 (Direct Cost: ¥4,300,000、Indirect Cost: ¥1,290,000)
Fiscal Year 2016: ¥5,720,000 (Direct Cost: ¥4,400,000、Indirect Cost: ¥1,320,000)
Fiscal Year 2015: ¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
|
Keywords | Tumor / T cells / T cell receptor / HLAハプロタイプ / 腫瘍浸潤リンパ球 / TCR / T細胞受容体 / 免疫学 / 抗腫瘍効果 / HLA / ハプロタイプ / 癌 / T細胞 / 単一細胞解析 |
Outline of Final Research Achievements |
T cells play important roles to suppress cancer generation in vivo. Recently, cancer therapy using T cells has been studied. T cells recognize the complex of cancer antigens and HLA molecules on cancer cells and kill them. The structure of HLA molecules are different in individual persons and T cells from a person whose HLA haplotype is different from a patient's HLA haplotype can not be used for the treatment of the patient. Major Japanese populations have HLA-A2 or A24 molecules. Thus, T cells recognizing cancer antigens in the context of HLA-A2 or A24 are studied, but those recognizing other HLA molecules are not. In this study, we have developed the method to find cancer-specific T cells independently of HLA haplotypes.
|
Report
(4 results)
Research Products
(38 results)
-
-
-
-
-
-
[Journal Article] Association Between High-Avidity T-Cell Receptors, Induced by α-Fetoprotein-Derived Peptides, and Anti-Tumor Effects in Patients With Hepatocellular Carcinoma2017
Author(s)
Nakagawa H, Mizukoshi E, Kobayashi E, Tamai T, Hamana H, Ozawa T, Kishi H, Kitahara M, Yamashita T, Arai K, Terashima T, Iida N, Fushimi K, Muraguchi A, Kaneko S
-
Journal Title
Gastroenterology
Volume: 152
Pages: 1395-1406
Related Report
Peer Reviewed
-
-
[Journal Article] Immunological features of T cells induced by human telomerase reverse transcriptase-derived peptides in patients with hepatocellular carcinoma.2015
Author(s)
E Mizukoshi, H Nakagawa, M Kitahara, T Yamashita, K Arai, H Sunagozaka, K Fushimi, E Kobayashi, H Kishi, A Muraguchi, S Kaneko.
-
Journal Title
Cancer Lett
Volume: 364
Issue: 2
Pages: 98-105
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Identification of broadly conserved cross-species protective Leishmania antigen and its responding CD4 + T cells2015
Author(s)
Z. Mou, J. Li, T. Boussoffara, H. Kishi, H. Hamana, P. Ezzati, C. Hu, W. Yi, D. Liu, F. Khadem, I. Okwor, P. Jia, K. Shitaoka, S. Wang, M. Ndao, C. Petersen, J. Chen, S. Rafati, H. Louzir, A. Muraguchi, J. a Wilkins, and J. E. Uzonna,
-
Journal Title
Science Translational Medicine
Volume: 7
Issue: 310
Pages: 1-13
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-